Stock Events
Stock Events
Features
Business
More
Login
Sign Up
Sign Up
Oruka Therapeutics (HQ1.F) Q4 2024 Earnings
HQ1.F
13
Nov
Confirmed
Q3 2024
Q4 2024
-1.38
-1.05
-0.71
-0.38
Details
Expected EPS
-0.38046265399999996
Actual EPS
-1.3821236
Surprise EPS
-1
Surprise Percent
+263.27%
Description
Oruka Therapeutics (HQ1.F) has reported earnings of -1.3821236 per share for Q4 2024.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login